{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:17:36Z","timestamp":1778026656965,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-22-967786"],"award-info":[{"award-number":["AARF-22-967786"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG067021"],"award-info":[{"award-number":["R01AG067021"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG036694"],"award-info":[{"award-number":["P01AG036694"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG036694"],"award-info":[{"award-number":["P01AG036694"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG058825-01A"],"award-info":[{"award-number":["R01AG058825-01A"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-024-01347-7","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T09:20:16Z","timestamp":1736760016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Detecting early cognitive deficits in preclinical Alzheimer\u2019s disease using a remote digital multi-day learning paradigm"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-4790","authenticated-orcid":false,"given":"Roos J.","family":"Jutten","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9099-7294","authenticated-orcid":false,"given":"Daniel","family":"Soberanes","sequence":"additional","affiliation":[]},{"given":"Cassidy P.","family":"Molinare","sequence":"additional","affiliation":[]},{"given":"Stephanie","family":"Hsieh","sequence":"additional","affiliation":[]},{"given":"Michelle E.","family":"Farrell","sequence":"additional","affiliation":[]},{"given":"Aaron S.","family":"Schultz","sequence":"additional","affiliation":[]},{"given":"Dorene M.","family":"Rentz","sequence":"additional","affiliation":[]},{"given":"Gad A.","family":"Marshall","sequence":"additional","affiliation":[]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[]},{"given":"Rebecca E.","family":"Amariglio","sequence":"additional","affiliation":[]},{"given":"Kathryn V.","family":"Papp","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1347_CR2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/ana.26891","volume":"95","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Timing of biomarker changes in sporadic Alzheimer's disease in estimated years from symptom onset. Ann. Neurol. 95, 951\u2013965 (2024).","journal-title":"Ann. Neurol."},{"key":"1347_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 7, 280\u2013292 (2011).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR4","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","volume":"13","author":"EC Mormino","year":"2017","unstructured":"Mormino, E. C. et al. Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u03b2. Alzheimer\u2019s Dement. 13, 1004\u20131012 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207978","volume":"102","author":"MA Dubbelman","year":"2024","unstructured":"Dubbelman, M. A. et al. Cognitive and functional change over time in cognitively healthy individuals according to Alzheimer disease biomarker-defined subgroups. Neurology 102, e207978 (2024).","journal-title":"Neurology"},{"key":"1347_CR6","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","volume":"389","author":"RA Sperling","year":"2023","unstructured":"Sperling, R. A. et al. Trial of solanezumab in preclinical Alzheimer\u2019s disease. N. Engl. J. Med. 389, 1096\u20131107 (2023).","journal-title":"N. Engl. J. Med."},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jalz.2019.09.085","volume":"16","author":"RJ Caselli","year":"2020","unstructured":"Caselli, R. J. et al. Neuropsychological decline up to 20 years before incident mild cognitive impairment. Alzheimer's Dement. 16, 512\u2013523 (2020).","journal-title":"Alzheimer's Dement."},{"key":"1347_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1037\/neu0000208","volume":"29","author":"J Hassenstab","year":"2015","unstructured":"Hassenstab, J. et al. Absence of practice effects in preclinical Alzheimer\u2019s disease. Neuropsychology 29, 940\u2013948 (2015).","journal-title":"Neuropsychology"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1080\/13854046.2013.836567","volume":"27","author":"MM Machulda","year":"2013","unstructured":"Machulda, M. M. et al. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging. Clin. Neuropsychol. 27, 1247\u20131264 (2013).","journal-title":"Clin. Neuropsychol."},{"key":"1347_CR10","first-page":"e12055","volume":"12","author":"RJ Jutten","year":"2020","unstructured":"Jutten, R. J. et al. Lower practice effects as a marker of cognitive performance and dementia risk: A literature review. Alzheimer\u2019s Dement: Diagnos, Assess. Dis. Monit. 12, e12055 (2020).","journal-title":"Alzheimer\u2019s Dement: Diagnos, Assess. Dis. Monit."},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"e2577","DOI":"10.1212\/WNL.0000000000010728","volume":"95","author":"YY Lim","year":"2020","unstructured":"Lim, Y. Y. et al. Association of deficits in short-term learning and A\u03b2 and hippocampal volume in cognitively normal adults. Neurology 95, e2577\u2013e2585 (2020).","journal-title":"Neurology"},{"key":"1347_CR12","doi-asserted-by":"crossref","unstructured":"Samaroo, A. et al. Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s and Dement: Diagnos, Assess. Dis. Monit. 12, (2020).","DOI":"10.1002\/dad2.12132"},{"key":"1347_CR13","unstructured":"Papp, K. V. et al. Unsupervised mobile cognitive testing for use in preclinical Alzheimer\u2019s disease. Alzheimer\u2019s and Dement: Diagnos, Assess. Dis. Monit. 13, (2021)."},{"key":"1347_CR14","doi-asserted-by":"crossref","unstructured":"Jutten, R. J. et al. Monthly at-home computerized cognitive testing to detect diminished practice effects in preclinical Alzheimer\u2019s disease. Front Aging Neurosci 13, (2022).","DOI":"10.3389\/fnagi.2021.800126"},{"key":"1347_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1037\/neu0000933","volume":"38","author":"EL Weizenbaum","year":"2023","unstructured":"Weizenbaum, E. L. et al. Capturing learning curves with the multiday Boston Remote Assessment of Neurocognitive Health (BRANCH): Feasibility, reliability, and validity. Neuropsychol. 38, 198\u2013210 (2023).","journal-title":"Neuropsychol."},{"key":"1347_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ana.26833","volume":"95","author":"KV Papp","year":"2024","unstructured":"Papp, K. V. et al. Early detection of amyloid-related changes in memory among cognitively unimpaired older adults with daily digital testing. Ann. Neurol. 95, 507\u2013517 (2024).","journal-title":"Ann. Neurol."},{"key":"1347_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack, C. R. Jr et al. NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR18","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer's & Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimer's & Dement."},{"key":"1347_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc0655","volume":"13","author":"JS Sanchez","year":"2021","unstructured":"Sanchez, J. S. et al. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci. Transl. Med 13, eabc0655 (2021).","journal-title":"Sci. Transl. Med"},{"key":"1347_CR20","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1093\/brain\/awz154","volume":"142","author":"A Maass","year":"2019","unstructured":"Maass, A. et al. Alzheimer\u2019s pathology targets distinct memory networks in the ageing brain. brain 142, 2492\u20132509 (2019).","journal-title":"brain"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"1347_CR22","doi-asserted-by":"crossref","unstructured":"Barnett, A. J., & Ranganath, C. Learning and memory. In G. G. Brown, B. Crosson, K. Y. Haaland, & T. Z. King (Eds.), American Psychological Association handbook of neuropsychology: Neuroscience and neuromethods, 77\u201395 (2023).","DOI":"10.1037\/0000308-004"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2018.05.006","volume":"680","author":"MJ Sekeres","year":"2018","unstructured":"Sekeres, M. J., Winocur, G. & Moscovitch, M. The hippocampus and related neocortical structures in memory transformation. Neurosci. Lett. 680, 39\u201353 (2018).","journal-title":"Neurosci. Lett."},{"key":"1347_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/ana.26813","volume":"95","author":"X Chen","year":"2024","unstructured":"Chen, X., Toueg, T. N., Harrison, T. M., Baker, S. L. & Jagust, W. J. Regional Tau deposition reflects different pathways of subsequent neurodegeneration and memory decline in cognitively normal older adults. Ann. Neurol. 95, 249\u2013259 (2024).","journal-title":"Ann. Neurol."},{"key":"1347_CR25","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182166e96","volume":"76","author":"BC Dickerson","year":"2011","unstructured":"Dickerson, B. C. et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 76, 1395\u20131402 (2011).","journal-title":"Neurology"},{"key":"1347_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jalz.2013.01.004","volume":"10","author":"RJ Caselli","year":"2014","unstructured":"Caselli, R. J. et al. The neuropsychology of normal aging and preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 10, 84\u201392 (2014).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR27","first-page":"e12217","volume":"13","author":"F \u00d6hman","year":"2021","unstructured":"\u00d6hman, F., Hassenstab, J., Berron, D., Sch\u00f6ll, M. & Papp, K. V. Current advances in digital cognitive assessment for preclinical Alzheimer's disease. Alzheimer's & Dement: Diagnos, Assess. Dis. Monit. 13, e12217 (2021).","journal-title":"Alzheimer's & Dement: Diagnos, Assess. Dis. Monit."},{"key":"1347_CR28","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200137","volume":"98","author":"ME Farrell","year":"2022","unstructured":"Farrell, M. E. et al. Association of emerging \u03b2-amyloid and tau pathology with early cognitive changes in clinically normal older adults. Neurology 98, e1512 (2022).","journal-title":"Neurology"},{"key":"1347_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling, R. A. et al. The impact of amyloid\u2010beta and tau on prospective cognitive decline in older individuals. Ann. Neurol. 85, 181\u2013193 (2019).","journal-title":"Ann. Neurol."},{"key":"1347_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/S135561772200042X","volume":"29","author":"J Nicosia","year":"2023","unstructured":"Nicosia, J. et al. Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer\u2019s disease. J. Int. Neuropsychol. Soc. 29, 459\u2013471 (2023).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"1347_CR31","volume":"14","author":"LI Thompson","year":"2022","unstructured":"Thompson, L. I. et al. A highly feasible, reliable, and fully remote protocol for mobile app\u2010based cognitive assessment in cognitively healthy older adults. Alzheimer\u2019s Dement.: Diagn., Assess. Dis. Monit. 14, e12283 (2022).","journal-title":"Alzheimer\u2019s Dement.: Diagn., Assess. Dis. Monit."},{"key":"1347_CR32","volume":"15","author":"LI Thompson","year":"2023","unstructured":"Thompson, L. I. et al. Remote and in\u2010clinic digital cognitive screening tools outperform the MoCA to distinguish cerebral amyloid status among cognitively healthy older adults. Alzheimer\u2019s Dement.: Diagn. Assess. Dis. Monit. 15, e12500 (2023).","journal-title":"Alzheimer\u2019s Dement.: Diagn. Assess. Dis. Monit."},{"key":"1347_CR33","doi-asserted-by":"crossref","unstructured":"Tsoy, E. et al. Scalable plasma and digital cognitive markers for diagnosis and prognosis of Alzheimer\u2019s disease and related dementias. Alzheimer\u2019s Dement. 20, 2089\u20132101 (2024).","DOI":"10.1002\/alz.13686"},{"key":"1347_CR34","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1212\/WNL.0b013e3182872ded","volume":"80","author":"S Weintraub","year":"2013","unstructured":"Weintraub, S. et al. Cognition assessment using the NIH Toolbox. Neurology 80, S54\u2013S64 (2013).","journal-title":"Neurology"},{"key":"1347_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1474-4422(22)00225-3","volume":"21","author":"RC Gershon","year":"2022","unstructured":"Gershon, R. C. et al. The Mobile Toolbox for monitoring cognitive function. Lancet Neurol. 21, 589\u2013590 (2022).","journal-title":"Lancet Neurol."},{"key":"1347_CR36","first-page":"e12423","volume":"15","author":"JC Taylor","year":"2023","unstructured":"Taylor, J. C. et al. Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research. Alzheimer\u2019s Dement: Diagnos. Assess. Dis. Monit. 15, e12423 (2023).","journal-title":"Alzheimer\u2019s Dement: Diagnos. Assess. Dis. Monit."},{"key":"1347_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.579934","volume":"11","author":"AP Owens","year":"2020","unstructured":"Owens, A. P. et al. Implementing remote memory clinics to enhance clinical care during and after COVID-19. Front Psychiatry 11, 579934 (2020).","journal-title":"Front Psychiatry"},{"key":"1347_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/alz.12797","volume":"19","author":"MW Weiner","year":"2023","unstructured":"Weiner, M. W. et al. Increasing participant diversity in AD research: plans for digital screening, blood testing, and a community\u2010engaged approach in the Alzheimer\u2019s disease Neuroimaging Initiative 4. Alzheimer\u2019s Dement. 19, 307\u2013317 (2023).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41746-024-00999-9","volume":"7","author":"D Berron","year":"2024","unstructured":"Berron, D. et al. A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices. NPJ Digit Med 7, 79 (2024).","journal-title":"NPJ Digit Med"},{"key":"1347_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1037\/neu0000905","volume":"38","author":"AJ Aschenbrenner","year":"2023","unstructured":"Aschenbrenner, A. J., Hassenstab, J., Morris, J. C., Cruchaga, C. & Jackson, J. J. Relationships between hourly cognitive variability and risk of Alzheimer\u2019s disease revealed with mixed-effects location scale models. Neuropsychol. 38, 69\u201380 (2023).","journal-title":"Neuropsychol."},{"key":"1347_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S1355617723000322","volume":"30","author":"NH Stricker","year":"2024","unstructured":"Stricker, N. H. et al. Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test. J. Int. Neuropsychol. Soc. 30, 138\u2013151 (2024).","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"1347_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12043","volume":"6","author":"S Perin","year":"2020","unstructured":"Perin, S. et al. Unsupervised assessment of cognition in the Healthy Brain Project: Implications for web-based registries of individuals at risk for Alzheimer\u2019s disease. Alzheimer\u2019s Dement.: Transl. Res. Clin. Interventions 6, e12043 (2020).","journal-title":"Alzheimer\u2019s Dement.: Transl. Res. Clin. Interventions"},{"key":"1347_CR43","doi-asserted-by":"publisher","first-page":"e16792","DOI":"10.2196\/16792","volume":"22","author":"R Backx","year":"2020","unstructured":"Backx, R., Skirrow, C., Dente, P., Barnett, J. H. & Cormack, F. K. Comparing web-based and lab-based cognitive assessment using the Cambridge neuropsychological test automated battery: A within-subjects counterbalanced study. J. Med. Internet Res. 22, e16792\u2013e16792 (2020).","journal-title":"J. Med. Internet Res"},{"key":"1347_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/bmm.12.49","volume":"6","author":"JW Bartlett","year":"2012","unstructured":"Bartlett, J. W. et al. Determining cut-points for Alzheimer\u2019s disease biomarkers: Statistical issues, methods and challenges. Biomark. Med. 6, 391\u2013400 (2012).","journal-title":"Biomark. Med."},{"key":"1347_CR45","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/alz.12356","volume":"17","author":"R Ossenkoppele","year":"2021","unstructured":"Ossenkoppele, R. & Hansson, O. Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 17, 1998\u20132008 (2021).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13195-022-00986-w","volume":"14","author":"AJ Weigand","year":"2022","unstructured":"Weigand, A. J., Maass, A., Eglit, G. L. & Bondi, M. W. What\u2019s the cut-point?: a systematic investigation of tau PET thresholding methods. Alzheimers Res. Ther. 14, 49 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"1347_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack","year":"2017","unstructured":"Jack, C. R. et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 13, 205\u2013216 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR48","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1212\/WNL.0b013e318295d7a1","volume":"80","author":"SE Monsell","year":"2013","unstructured":"Monsell, S. E. et al. Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology. Neurology 80, 2121\u20132129 (2013).","journal-title":"Neurology"},{"key":"1347_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuroimage.2015.03.069","volume":"144","author":"A Dagley","year":"2017","unstructured":"Dagley, A. et al. Harvard aging brain study: Dataset and accessibility. Neuroimage 144, 255\u2013258 (2017).","journal-title":"Neuroimage"},{"key":"1347_CR50","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jalz.2019.09.074","volume":"16","author":"KV Papp","year":"2020","unstructured":"Papp, K. V. et al. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimer\u2019s Dement. 16, 552\u2013560 (2020).","journal-title":"Alzheimer\u2019s Dement."},{"key":"1347_CR51","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/13854046.2014.911351","volume":"28","author":"KV Papp","year":"2014","unstructured":"Papp, K. V. et al. Development of a psychometrically equivalent short form of the face\u2013name associative memory exam for use along the early Alzheimer\u2019s disease trajectory. Clin. Neuropsychol. 28, 771\u2013785 (2014).","journal-title":"Clin. Neuropsychol."},{"key":"1347_CR52","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1037\/0882-7974.20.4.718","volume":"20","author":"AD Castel","year":"2005","unstructured":"Castel, A. D. Memory for grocery prices in younger and older adults: the role of schematic support. Psychol. Aging 20, 718 (2005).","journal-title":"Psychol. Aging"},{"key":"1347_CR53","first-page":"498","volume":"22","author":"D Wechsler","year":"2008","unstructured":"Wechsler, D. Wechsler adult intelligence scale\u2013Fourth Edition (WAIS\u2013IV). San. Antonio, TX: NCS Pearson 22, 498 (2008).","journal-title":"San. Antonio, TX: NCS Pearson"},{"key":"1347_CR54","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson, K. A. et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann. Neurol. 79, 110\u2013119 (2016).","journal-title":"Ann. Neurol."},{"key":"1347_CR55","doi-asserted-by":"publisher","first-page":"1760 LP","DOI":"10.1212\/WNL.0000000000000431","volume":"82","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Amyloid and emAPOE \u03b54\/em interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82, 1760 LP\u20131767 (2014).","journal-title":"Neurology"},{"key":"1347_CR56","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1212\/WNL.0000000000011214","volume":"96","author":"ME Farrell","year":"2021","unstructured":"Farrell, M. E. et al. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation. Neurology 96, e619\u2013e631 (2021).","journal-title":"Neurology"},{"key":"1347_CR57","doi-asserted-by":"publisher","first-page":"62627","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens, D. Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Front Psychol. 4, 62627 (2013).","journal-title":"Front Psychol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01347-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:40:19Z","timestamp":1736804419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1038\/s41746-024-01347-7","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.A.M. has received research salary support for serving as site principal investigator for clinical trials funded by Eisai Inc., Eli Lilly and Company, and Genentech; this work is not related to the current study. R.A.S. has served as a consultant for Abbvie, AC Immune, Acumen, Alector, Biohaven, Bristol-Myers Squibb, Genentech\/Roche, Ionis, Janssen, Merck, Oligomerix, Prothena, Vaxxinity. She has research funding, but no salary support or personal income for public-private partnership trials from Eisai and Co., and Eli Lilly and Co. This work is not related to the current study. All other authors declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}